Results 41 to 50 of about 112,352 (251)

Chimera CRD1 Domain

open access: yes, 2023
Fig. 5, Chimera structural analysis of the CRD1 domain of the domestic cat CD134 receptor. The structure used for this Chimera analysis was obtained through AlphaFold. Highlighted in red are the amino acid sequences 31-65 that comprise the CRD1 domain of
Matthew Nguyen (14780485)
core   +1 more source

Mechanically Spatio‐Chimeric Fibrin Assembly Enables Vascular‐Integrated Muscle Reconstruction for Volumetric Muscle Loss Repair

open access: yesAdvanced Materials, EarlyView.
SPARC (spatio‐chimeric, plasma‐based, anisotropic, and shear‐responsive construct) that integrates myogenic and vascular microenvironments within a single construct. The dual‐modulus matrix directs aligned myotube formation and endothelial network development, enabling a vascularized muscle implant that seamlessly anastomoses with host tissue and ...
Su Hyun Jung   +6 more
wiley   +1 more source

Chimera and globally clustered chimera: impact of time delay [PDF]

open access: yes, 2010
Following a short report of our preliminary results [Sheeba et al., Phys. Rev. E 79, 055203(R) (2009)], we present a more detailed study of the effects of coupling delay in diffusively coupled phase oscillator populations.
Lakshmanan, M.   +2 more
core   +1 more source

Chromosomal Instability Drives Glioblastoma Heterogeneity and Therapeutic Opportunities

open access: yesAdvanced Science, EarlyView.
ABSTRACT Glioblastoma, the most aggressive and lethal form of brain cancer, is defined by profound genomic instability, with Chromosomal Instability (CIN) playing a central role in driving tumor progression, therapy resistance, and poor prognosis. CIN is characterized by numerical and structural alterations, is driven by mechanisms such as mitotic ...
Amarnath Pal   +3 more
wiley   +1 more source

PD‐1 Inhibits CD4+ TRM‐Mediated cDC1 Mobilization via Suppressing JAML in Human NSCLC

open access: yesAdvanced Science, EarlyView.
CD4+ tissue‐resident memory T cells (TRMs) in non‐small cell lung cancer recruit conventional type 1 dendritic cells via XCL1‐XCR1 signaling, orchestrating antitumor immunity. The costimulatory molecule JAML is essential for this process. PD‐1 blockade restores JAML expression and cDC1 mobilization, while JAML agonists synergize with anti‐PD‐1 therapy,
Zheyu Shao   +16 more
wiley   +1 more source

CHIMERA: v1.0.0

open access: yes
<p><strong>CHIMERA</strong> (Combined Hierarchical Inference Model for Electromagnetic and gRavitational-wave Analysis) is a flexible Python code to analyze standard sirens with galaxy catalogs, allowing for a joint fitting of the ...
Borghi, Nicola   +2 more
core   +1 more source

Anti‐PD‐1 Nanobody‐Armored MSLN CAR‐T Therapy for Malignant Mesothelioma: Preclinical and Clinical Studies

open access: yesAdvanced Science, EarlyView.
A novel therapy using engineered immune cells (NAC‐T cells) showed promise for refractory malignant mesothelioma. Based on the encouraging preclinical data, the first‐in‐human trial is initiated, demonstrating tolerable safety and promising anti‐tumor activity (ORR 63.6%, DCR 100%, including one CR).
Yan Sun   +23 more
wiley   +1 more source

Controlling unstable chaos: stabilizing chimera states by feedback [PDF]

open access: yes, 2013
Copyright © 2014 American Physical SocietyWe present a control scheme that is able to find and stabilize an unstable chaotic regime in a system with a large number of interacting particles.
Sieber, Jan   +4 more
core   +1 more source

Chimera dynamics in nonlocally coupled bicomponent oscillators

open access: yes, 2021
The chimera state, characterized by the coexistence of coherent and incoherent domains, has become an active research field. In this work, we consider a ring of nonlocally coupled bicomponent FitzHugh-Nagumo oscillators by randomly partitioning ...
Peiyu Wang   +3 more
core   +1 more source

CDK4/6 Inhibition Induces CD8+ T Cell Antitumor Immunity via MIF‐Induced Functional Orchestration of Tumor‐Associated Macrophages

open access: yesAdvanced Science, EarlyView.
CDK4/6 inhibition promotes CD8+ T cell expansion through tumor‐macrophage crosstalk by activating HIF‐1α and enhancing MIF‐CD44/CD74 signaling. This reprograms TAMs to boost MHC‐I antigen presentation, and CDK4/6 inhibitor‐trained M1 TAM supernatant therapy synergizes with low‐dose PD‐1 blockade to restore antitumor immunity.
Lin He   +17 more
wiley   +1 more source

Home - About - Disclaimer - Privacy